Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis.

Thoracic cancer - 1 May 2018

Fan Hongwei, Li Chao, Xiang Qian, Xu Ling, Zhang Zhuo, Liu Qianxin, Zhang Tonttong, Zhou Ying, Zhao Xia, Cui Yimin

Abstract excerpt

BACKGROUND: PIK3CA mutations frequently occur in breast cancer patients. This study was conducted to evaluate the relationship between PIK3CA mutations and neoadjuvant treatment response and to analyze the clinical implications. METHODS: PubMed, Embase, and the Cochrane database were searched for relevant studies in September 2017. The pooled risk ratio (RR) was estimated using fixed effects or random effects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Disease-Free Survival

Share to Neoadjuvant Therapy

Share to Neoplasm Staging

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 29575819
DOI: 10.1111/1759-7714.12618
PMCID: PMC5928352

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis.PMID 29575819Read ↗

An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials.Semantic proximity Read ↗

Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.Semantic proximity Read ↗

Clinicopathological and prognostic analysis of PIK3CA mutated invasive breast cancer in Chinese women.Semantic proximity Read ↗

Spectrum of PIK3CA/AKT mutations across molecular subtypes of triple-negative breast cancer.Semantic proximity Read ↗

PIK3CA gene mutation status associated with poor prognosis of breast cancer: a retrospective cohort studySemantic proximity Read ↗

Analysis of PIK3CA Mutations with Clinicopathological Features and Prognosis in Breast cancer patients with Undergoing Neoadjuvant TherapySemantic proximity Read ↗

Survival analysis of patients with early breast cancer associated with PIK3CA mutationSemantic proximity Read ↗

PIK3CA mutations in breast cancer: A Tunisian series.Semantic proximity Read ↗

PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.Semantic proximity Read ↗

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.Semantic proximity Read ↗

PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients.Semantic proximity Read ↗

Analysis of PIK3CA mutations in breast cancer subtypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.